NTI 2.99% 6.9¢ neurotech international limited

Ann: US Clinical Trial Results Published, page-10

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 953 Posts.
    lightbulb Created with Sketch. 180
    I don't think the market has factored in just how near term revenue is. They probably think, only $3M in the bank, will it last till FDA achieved? However, CE Mark and TGA are already there, what we were waiting upon was scientifically robust clinical trials which are now announced. The PR machine from each of the distributors should now wind up (I think @Red bar already posted a nice article in Greece). Parents of Autistic children can have their lives changed with this device so I expect will be happy to invest in this. And then there will be lobbying for reimbursements from government who also stand to save big dollars from efficient home based Autism treatment.

    I was really pleased to see the advice that the new improved stock will be available from August. I expect sales in Q3 and the margin on these devices is fantastic.
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
6.9¢
Change
0.002(2.99%)
Mkt cap ! $64.55M
Open High Low Value Volume
6.7¢ 7.2¢ 6.7¢ $45.29K 648.2K

Buyers (Bids)

No. Vol. Price($)
3 684701 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.9¢ 100000 1
View Market Depth
Last trade - 15.37pm 22/11/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.